Prebiotics in infant formulae. Could we modify the immune response?;Prebióticos en las fórmulas para lactantes. ¿Podemos modificar la respuesta inmune?

Anales de Pediatria

Volumn 68, Issue 3, 2008, Pages 286-294

  Moreno Villares, J M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Allergy; Immunity; Infant formula; Intestinal microflora; Oligosaccharide; Prebiotic

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BACTERIAL METABOLISM; BIFIDOBACTERIUM; BREAST MILK; COLON FLORA; FECES; HIGH RISK INFANT; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; INTESTINE INFECTION; PATHOGENESIS; PH; PREMATURITY; RISK; SMALL INTESTINE; UPPER RESPIRATORY TRACT INFECTION;

EID: 41549108448     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13116712     Document Type: Article

References (64)

1. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interations shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 2002;22:283-307.
2. Sanz Y, Collado MC, Haros M, Dalmau J. Funciones metabólico- nutritivas de la microbiota intestinal y su modulación a través de la dieta: probióticos y prebióticos. Acta Pediatr Esp. 2004;62:520-6.
3. Bach JF. The effect of infections on susceptibility to autoimmune and allergic disease. N Engl J Med. 2002;347:911-20.
4. Renz H, Blumer N, Virna S, Sel S, Garn H. The immunological basis of the hygiene hypothesis. Chem Immunol Allergy. 2006;91:30-48.
5. Moore SE, Collison AC, Tamba N'Gom P, Aspinall R, Prentice AM. Early immunological development and mortality from infectious disease in later life. Proc Nutr Soc. 2006;65:311-8.
6. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-12.
7. Cummings JH, Macfarlane GT. Gastrointestinal effects of prebiotics. Br J Nutr. 2002;87 Suppl 2:S145-51.
8. Delzenne NM. Oligosaccharides: state of the art. Proceed Nutr Soc. 2003;62:177-82.
9. Rose HP, Kleesen B, Blaut M. Effects of insulin on faecal bifidobacteria in human subjects. Br J Nutr. 1999;82:375-82.
10. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol Suppl. 1997;39:635-40.
11. Bouhnik Y, Flourie B, D'Agay-Abensour L, Pochart P, Gramet G, Duraud M, et al. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 1997;127:444-8.
12. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the large intestine. J Appl Bacteriol. 1993;75:373-80.
13. Rumessen JJ, Bode S, Hamberg O, Hoyer EG. Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation and influence on blood glucose, insuline and C-peptide responses in healthy subjects. Am J Clin Nutr. 1990;52:675-81.
14. Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proceed Nutr Soc. 2003;62:95-99.
15. Tahiri M, Tressol JC, Arnaud J, Bornet FR, Bauteloup-Demange C, Feillet-Coudray C, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr. 2003;77:449-57.
16. Pool-Zobel B, Van Loo J, Rowland I, Roberfroid M. Experimental evidences on the potential of prebiotics fructans to reduce the risk of colon cancer. Br J Nutr. 2002;87 Suppl 2:S273-81.
17. Andoh A, Tomoyuki T, Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr Pharm Des. 2003;9:347-58.
18. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;360:512-9.
19. Wollowski I, Rechkemmer G, Pool-Zobel B. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr. 2002;73:S451-5.
20. López HW, Levrat-Verny MA, Coudray C, Besson C, Krespine V, Messager A, et al. Class 2 resistant starches lower plasma and liver lipids and improve mineral retention in rats. J Nutr. 2001;131:1283-9.
21. Van Loo JAE. Prebiotics promote good health. The basis, the potential, and the emerging evidence. J Clin Gastroenterol. 2004;38:S70-5.
22. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-7.
23. Magne F, Suau A, Pochart P, Desjeux JF. Fecal microbial community in preterm infants. J Pediatr Gastroenterol Nutr. 2005;41:386-92.
24. Westerbeek AM, van den Berg A, Lafeber HN, Knol J, Fetter WPF, Van Elburg RM. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr. 2006;25:361-8.
25. Newburg DS, Neubauer SH. Carbohydrates in milks: Analysis, quantities, and significance. En: Jensen RG, editor. Handbook of milk composition. San Diego: Academic Press; 1995. p. 273-349.
26. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. The first prebiotics in humans. Human milk oligosaccharides. J Clin Gastroenterol. 2004;38:S80-S3.
27. Vitoria Miñana I. Oligosacáridos en la leche humana. Acta Pediatr Esp. 2007;65:129-33.
28. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic effcts. Annu Rev Nutr. 2000;20:699-722.
29. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human Milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 2005;25:37-58.
30. Morrow AL, Ruiz-Palacios GM, Altaye M, Guerrero L, Meinzen-Derr JK, Farkas T, et al. Human milk oligosaccharides are associated with protection against diarrea in breast-fed infants. J Pediatr. 2004;145:297-303.
31. Martín R, Langa S, Reviriego C, Jiménez E, Marín ML, Xaus X, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143:754-8.
32. Martín R, Jiménez E, Olivares M, Marín ML, Fernández L, Xaus J, et al. Lactobacillus salivarius CECT 5713, a potential probiotic strain isolated from infant feces and breast milk of a mother-child pair Intl J Food Microbiol. 2006;112:35-43
33. Vandenplas Y. Oligosaccharides in infant formula. Br J Nutr. 2002;87:S293-S6.
34. Fanaro S, Boehm G, Garssen J, Knol J, Mosca F, Stahl B, et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review. Acta Paediatr. 2005;94 Suppl 449:22-6.
35. Vitoria Miñana I. Oligosacáridos en nutrición infantil: fórmula infantil, alimentación complementaria y del adolescente. Acta Pediatr Esp. 2007;65:175-9.
36. Boehm G, Jelinek J, Stahl B, Van Laere K, Knol J, Fanaro S, et al. Prebiotics in infant formula. J Clin Gastroenterol. 2004;38:S76-S9.
37. Bohem G, Fanaro S, Jelinek J, Stahl B, Marini A. Prebiotic concept for infant nutrition. Acta Paediatr. 2003;91:S64-S7.
38. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995;108:975-82.
39. Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86:F178-81.
40. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JM, Bindels JG. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr. 2005;94:783-90.
41. Knol J, Scholtens P, Kafka C, Steenbakkers J, Grob S, Helm K, et al. Colon microflora in infants fed formula with galacto- and fructo- oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36-42.
42. Arman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Applied Environmental Microbiology. 2005;71:2318-24.
43. Euler AR, Mitchell DK, Kline R, Pickering LK. Prebiotic effect of fructo-oligosaccharide supplemneted term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr. 2005;40:157-64.
44. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34:291-5
45. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Acidic oligosaccharides from pectin hydrolisate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr. 2005;41:186-90.
46. Knol J, Boehm G, Lidestri M, Negretti F, Jelinek J, Agosti M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faces of formula-fed infants. Acta Paediatr. 2005;94:S31-3.
47. Marteau P, Flourié B. Tolerance to low-digestive carbohydrates: symptomatology and methods. Br J Nutr. 2001;85 Suppl 1:S17-21.
48. Piche T, Bruley des Varannes S, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP, et al. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003;124:894-902.
49. Marteau P, Seksik P. Tolerance of probiotics and prebiotics. J Clin Gastroenterol. 2004;38 Suppl 2:S67-9.
50. EC Scientific Committee on Food. Additional statement on the use of resistant short chain carbohydrates (oligofructosyl-saccharose and oligogalactosyl-lactose) in infant formulae and in follow-on formulae. Brussels: COMEUR; 13 December 2001.
51. Directiva 2006/141/CE de la Comisión del 22 de diciembre de 2006 relativa a los preparados para lactantes y preparados de continuación y por la que se modifica la Directiva 1999/21/CE. Diario Oficial de la Unión Europea 30.12.2006; L 401/1-33.
52. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JWL, et al. ESPGHAN Committee on Nutrition. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:465-73.
53. Brunser O, Gotteland M, Cruchet S, Figueroa G, Garrido D, Steenhout P. Effect of milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr Res. 2006;59:451-6
54. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814-9.
55. Bruzzese E, Volpicelli M, Salvini F, Bisceglia M, Lionetti P, Conquetti M, et al. Effect of early administration of GOS/FOS on the prevention of intestinal and extra-intestinal infections in healthy infants. J Pediatr Gastroenterol Nutr. 2006;42:e95.
56. Mihatsch WA, Hoegel J, Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and acelerate gastrointestinal transport in preterm infants. Acta Paediatr. 2006;95:843-8.
57. Eiwegger T, Stahl B, Schmitt J, Boehm G, Gerstmayr M, Pichler J, et al. Human milk-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004;56:536-40.
58. Schelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolized protein, a high β-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003;36:343-51.
59. Savino F, Cresi F, Maccario S, Cavallo F, Dalmasso P, Fanaro S, et al. Minor feeding problems during the first months of life: effect of a partially hydrolized milk formula contanining fructo-and galacto-oligosaccharides. Acta Paediatr. 2003;441:S86-90.
60. Scholtens PA, Alles MS, Bindels JG, Van der Linde EG, Tolboom JJ, Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomized controlled clinical trial. J Pediatr Gastroenterol Nutr. 2006;42:553-9.
61. Moore N, Chao C, Yang LP, Oliva-Hemker M, Saavedra JM. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. Br J Nutr. 2003;90:581-7
62. Veereman-Wauters G. Application of prebiotics in infants foods. Br J Nutr. 2005;93 Suppl 1:S57-60.
63. Duggan C, Penny M, Hibberd P, Gil A, Huapaya A, Cooper A, et al. Oligofructose-supplemented infant cereal. 2. Randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr. 2003;77:937-42.
64. Hoekstra JH, Szajewska H, Zikri MA, Micetic-Turk D, Weizman Z, Papadopoulou A, et al. Oral rehydration solution containing a mixture of non-digestible carbohydrates in the treatment of acute diarrhea: a multicenter randomized placebo controlled study on behalf of the ESPGHAN Working Group on Intestinal Infections. J Pediatr Gastroenterol Nutr. 2004;39:239-45.